Literature DB >> 10995421

Increased formation of F(2)-isoprostanes in patients with severe heart failure.

J L Cracowski1, F Tremel, C Marpeau, J P Baguet, F Stanke-Labesque, J M Mallion, G Bessard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10995421      PMCID： PMC1729446          DOI： 10.1136/heart.84.4.439

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  17 in total

Review 1.  Antiarrhythmics--from cell to clinic: past, present, and future.

Authors:  J C Hancox; K C Patel; J V Jones
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

2.  Effect of pentoxifylline on apoptosis of cultured cells.

Authors:  F Belloc; C Jaloustre; P Dumain; F Lacombe; M Lenoble; M R Boisseau
Journal:  J Cardiovasc Pharmacol       Date:  1995       Impact factor: 3.105

3.  TNF-induced cardiomyopathy.

Authors:  S Hegewisch; H J Weh; D K Hossfeld
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

4.  Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Authors:  T Suda; T Takahashi; P Golstein; S Nagata
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

5.  Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

Authors:  N C Davidson; A A Naas; J K Hanson; N S Kennedy; W J Coutie; A D Struthers
Journal:  Am J Cardiol       Date:  1996-04-15       Impact factor: 2.778

6.  Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure.

Authors:  C M O'Connor; P A Gurbel; V L Serebruany
Journal:  Am J Cardiol       Date:  1999-05-01       Impact factor: 2.778

7.  A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Authors:  J D Morrow; K E Hill; R F Burk; T M Nammour; K F Badr; L J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Apoptosis in myocytes in end-stage heart failure.

Authors:  J Narula; N Haider; R Virmani; T G DiSalvo; F D Kolodgie; R J Hajjar; U Schmidt; M J Semigran; G W Dec; B A Khaw
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

9.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

Authors:  M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton
Journal:  Lancet       Date:  1997-11-08       Impact factor: 79.321

10.  Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure.

Authors:  J Nourooz-Zadeh; N K Gopaul; S Barrow; A I Mallet; E E Anggård
Journal:  J Chromatogr B Biomed Appl       Date:  1995-05-19
View more
  6 in total

1.  The putative role of isoprostanes in human cardiovascular physiology and disease: following the fingerprints.

Authors:  J-L Cracowski
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

2.  Quantification of urinary 8-iso-prostaglandin F2alpha using liquid chromatography-tandem mass spectrometry during cardiac valve surgery.

Authors:  Yun-Hui Teng; Chih-Wei Wang; Yun-Tsan Liao; Min-Wen Yang; Tsung-Yun Liu
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure.

Authors:  W H Wilson Tang; Yuping Wu; Shirley Mann; Michael Pepoy; Kevin Shrestha; Allen G Borowski; Stanley L Hazen
Journal:  Circ Heart Fail       Date:  2010-11-09       Impact factor: 8.790

4.  Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.

Authors:  Scott L Hummel; E Mitchell Seymour; Robert D Brook; Theodore J Kolias; Samar S Sheth; Hannah R Rosenblum; Joanna M Wells; Alan B Weder
Journal:  Hypertension       Date:  2012-10-01       Impact factor: 10.190

5.  Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress.

Authors:  M Nonaka-Sarukawa; K Yamamoto; H Aoki; H Takano; T Katsuki; U Ikeda; K Shimada
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

6.  Antagonism of the Thromboxane-Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy.

Authors:  James D West; Cristi L Galindo; Kyungsoo Kim; John Jonghyun Shin; James B Atkinson; Ines Macias-Perez; Leo Pavliv; Bjorn C Knollmann; Jonathan H Soslow; Larry W Markham; Erica J Carrier
Journal:  J Am Heart Assoc       Date:  2019-10-30       Impact factor: 5.501
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.